The effect of Mediterranean diet on colorectal cancer, in the presence of the metabolic syndrome, was evaluated in 250 patients with first developed cancer (63 ± 12 years, 59% males) and 250 age–gender-matched controls. Adherence to the Mediterranean diet was evaluated with the modified-MedDietScore (theoretical range 0-75), while assessment of the metabolic syndrome (MetS) was based on the third Adult Treatment Panel ([ATP III] National Cholesterol Education Program) criteria. Presence of MetS (1.66, 95% confidence interval [CI] 1.02, 2.69), age (4.25, 95% CI 2.33, 7.77), smoking (1.85, 95% CI 1.27, 2.70), and family history of colorectal cancer (3.37, 95% CI 1.69, 6.75) had a detrimental effect, whereas adherence to the Mediterranean diet (0.88, 95% CI 0.84, 0.92) and body mass index (0.93, 95%CI 0.89, 0.98) had a protective role regarding colorectal cancer. Mediterranean diet had the same effect in relation to colorectal cancer, in both participants with (0.84, 95% CI 0.76, 0.93) and without MetS (0.89, 95% CI 0.85, 0.94).
World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective Report. Washington DC: AICR; 2007.
6.
WilliamsMTHordNG.The role of dietary factors in cancer prevention: beyond fruits and vegetables. Nutr Clin Pract. 2005;20(4):451–459.
7.
SmithSC.Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med. 2007;120(3 suppl 1):3–11.
8.
ChimonasTAthyrosVGGanotakisE. Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome. Angiology. 2010;61(1):49–57.
9.
GiovannucciE.Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(3):s836–s842.
10.
AshbeckELJacobsETMartinezMEGernerEWLancePThompsonPA.Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1134–1143.
11.
KanekoRSatoYAnY. Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma. Asian Pacific J Cancer Prev. 2010;11(4):975–983.
12.
StürmerTBuringJELeeIMGazianoJMGlynnRJ.Metabolic abnormalities and risk for colorectal cancer in the Physicians Health study. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2391–2397.
13.
AhmedRHSchmitzKHAndersonKERosamondWDFolsomAR.The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006;107(1):28–36.
14.
KimJHLimYJSungIK. Is metabolic syndrome a risk factor for colorectal adenoma?Cancer Epidemiol Biomarkers Prev. 2007;16(8):1543–1546.
15.
ChanAOOJimMHLamKF. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007;298(12):1412–1419.
16.
BowersKAlbanesDLimburgP. A prospective study of Anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol. 2006;164(7):652–664.
17.
MoritaTTabataSMineshitaMMizoueTMooreMAKonoS.The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self-defence forces health study. Asian Pacific J Cancer Prev. 2005;6(4):485–489.
18.
TsilidisKKBrancatiFLPollakMN. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010;21(1):1–10.
19.
PanagiotakosDB.α-Priori vs. α-posterior methods in dietary pattern analysis: a review in nutrition epidemiology. Nutr Bull. 2008;33(4):311–315.
20.
BountzioukaVBathrellouEGiotopoulouADevelopment, repeatability and validity regarding energy and macronutrient intake of a semi-quantitative food frequency questionnaire: Methodological considerations. Nutr Metab Cardiovasc Dis.2011;
21.
PanagiotakosDBPitsavosCArvanitiF. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults: the accuracy of the MedDietScore. Prev Med. 2007;44(4):335–340.
22.
Expert Panel on Detection Evaluation and treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
23.
FerrariPJenabMNoratT. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007;121(9):2065–2072.
24.
AlkerwiABoutsenMVaillantM. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis. 2009;204(2):624–635.
25.
LeeKWParkBJKangHTLeeYJ.Alcohol-drinking patterns and metabolic syndrome risk: the 2007 Korean national health and nutrition examination survey. Alcohol. 2011;45(5):499–505.
26.
PelucchiCNegriETalaminiR. Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer Prev. 2010;46(10):1866–1872.
27.
ColangeloLAGapsturSMGannPHDyerARLiuK.Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11(4):385–391.
28.
FranceschiSDal MasoLAugustinL. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001;12(2):173–178.
29.
EsfahaniAWongJMWMirrahimiASrichaikulKJenkinsDJKendallCW.The glycemic index: physiological significance. J Am Coll Nutr. 2009;28(suppl):439s–445s.
30.
HodaMRKeelySJBertelsenLSJungerWGDharmasenaDBarrettKE.Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg. 2007;94(3):346–354.
31.
ArtsICHollmanPC.Polyphenols and disease risk in epidemiological studies. Am J Clin Nutr. 2005;81(suppl 1):317s–325s.
32.
KastoriniCMMilionisHJEspositoKGiuglianoDGoudevenosJAPanagiotakosDB.The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299–1313.
33.
PelucchiCBosettiCNegriELipworthLLa VecchiaC.Olive oil and cancer risk: an update of epidemiological findings through 2010. Curr Pharm Des. 2011;17(8):805–812.
34.
CoronaGSpencerJPEDessìMA.Extra virgin olive oil phenolics: absorption, metabolism, and biological activities in the GI tract. Toxicol Ind Health. 2009;25(4-5):285–293.
35.
PaniaguaJAGallego de la SacristanaASánchezE. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26(5):434–444.
